AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
BONE-MARROW-DERIVED DENDRITIC CELLS DIRECTLY ACTIVATE ANTIGEN-SPECIFIC T-LYMPHOCYTES IN-VIVO
Authors: SCHNEEBERGER A KOSZIK F KOLESARIC A ELBEBURGER A STINGL G
Citation: A. Schneeberger et al., BONE-MARROW-DERIVED DENDRITIC CELLS DIRECTLY ACTIVATE ANTIGEN-SPECIFIC T-LYMPHOCYTES IN-VIVO, Journal of leukocyte biology, 1998, pp. 21-21
CONTACT HYPERSENSITIVITY AND TOLERANCE TO THE HAPTEN CAN BE INDUCED BY MHC CLASS I+ II- DENDRITIC CELLS/
Authors: KOLESARIC A ELBEBURGER A SCHNEEBERGER A STINGL G
Citation: A. Kolesaric et al., CONTACT HYPERSENSITIVITY AND TOLERANCE TO THE HAPTEN CAN BE INDUCED BY MHC CLASS I+ II- DENDRITIC CELLS/, Journal of investigative dermatology, 110(4), 1998, pp. 631-631
CD40 LIGAND EXPRESSION IN MURINE MELANOMA-CELLS ABROGATES THEIR TUMORIGENICITY AND INDUCES PROTECTIVE IMMUNITY
Authors: SCHNEEBERGER A BUSCHLE M LUHRS P KUTIL R SCHMIDT W STINGL G
Citation: A. Schneeberger et al., CD40 LIGAND EXPRESSION IN MURINE MELANOMA-CELLS ABROGATES THEIR TUMORIGENICITY AND INDUCES PROTECTIVE IMMUNITY, Journal of investigative dermatology, 110(4), 1998, pp. 718-718
PARTIAL REACTIONS OF THE NA,K-ATPASE - KINETIC-ANALYSIS AND TRANSPORT-PROPERTIES
Authors: APELL HJ SCHNEEBERGER A SOKOLOV VS
Citation: Hj. Apell et al., PARTIAL REACTIONS OF THE NA,K-ATPASE - KINETIC-ANALYSIS AND TRANSPORT-PROPERTIES, Acta Physiologica Scandinavica, 163, 1998, pp. 235-245
GENE-THERAPY FOR MELANOMA
Authors: STINGL G SCHNEEBERGER A
Citation: G. Stingl et A. Schneeberger, GENE-THERAPY FOR MELANOMA, European journal of cancer, 33, 1997, pp. 599-599
PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE
Authors: STINGL G BROCKER EB MERTELSMANN R WOLFF K SCHREIBER S KAMPGEN E SCHNEEBERGER A TRCKA J BRENNSCHEIDT U VEELKEN H BIRNSTIEL ML ZATLOUKAL K MAASS G WAGNER E BUSCHLE M KEMPE ER WEBER HA VOIGT T
Citation: G. Stingl et al., PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE, Journal of molecular medicine, 75(4), 1997, pp. 297-299
IL-2-BASED CANCER VACCINES - FAILURE OF MOUSE MELANOMA-CELLS PRODUCING HIGH AMOUNTS OF IL-2 TO INDUCE PROTECTIVE IMMUNITY IS NOT DUE TO TUMOR-SPECIFIC TOLERANCE
Authors: SCHNEEBERGER A SABOL M KUTIL R SCHMIDT W KOLESARIC A STINGL G
Citation: A. Schneeberger et al., IL-2-BASED CANCER VACCINES - FAILURE OF MOUSE MELANOMA-CELLS PRODUCING HIGH AMOUNTS OF IL-2 TO INDUCE PROTECTIVE IMMUNITY IS NOT DUE TO TUMOR-SPECIFIC TOLERANCE, Journal of investigative dermatology, 109(3), 1997, pp. 407-407
BONE-MARROW-DERIVED DENDRITIC CELLS DIRECTLY ACTIVATE ANTIGEN-SPECIFIC T-CELLS IN-VIVO
Authors: SCHNEEBERGER A KOSZIK F KOLESARIC A ELBEBURGER A STINGL G
Citation: A. Schneeberger et al., BONE-MARROW-DERIVED DENDRITIC CELLS DIRECTLY ACTIVATE ANTIGEN-SPECIFIC T-CELLS IN-VIVO, Journal of investigative dermatology, 109(2), 1997, pp. 65-65
CYTOKINE BASED CANCER VACCINES - FAILURE OF MURINE MELANOMA VACCINES PRODUCING HIGH AMOUNTS OF IL-2 TO INDUCE PROTECTIVE IMMUNITY IS NPT DUE TO TUMOR-SPECIFIC TOLERANCE
Authors: SCHNEEBERGER A KUTIL R SCHMIDT W KOLESARIC A STROMMER S STINGL G
Citation: A. Schneeberger et al., CYTOKINE BASED CANCER VACCINES - FAILURE OF MURINE MELANOMA VACCINES PRODUCING HIGH AMOUNTS OF IL-2 TO INDUCE PROTECTIVE IMMUNITY IS NPT DUE TO TUMOR-SPECIFIC TOLERANCE, Journal of investigative dermatology, 108(4), 1997, pp. 347-347
MURINE LANGERHANS CELLS GENERATED UNDER SERUM-FREE CONDITIONS - IMMUNOPHENOTYPE AND STIMULATORY CAPACITIES
Authors: KOCIKOVA A OLT S KOSZIK F SCHNEEBERGER A STINGL G ELBEBURGER A
Citation: A. Kocikova et al., MURINE LANGERHANS CELLS GENERATED UNDER SERUM-FREE CONDITIONS - IMMUNOPHENOTYPE AND STIMULATORY CAPACITIES, Journal of investigative dermatology, 108(4), 1997, pp. 435-435
PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE
Authors: STINGL G BROCKER EB MERTELSMANN R WOLFF K SCHREIBER S KAMPGEN E SCHNEEBERGER A DUMMER W BRENNSCHEID U VEELKEN H BIRNSTIEL ML ZATLOUKAL K SCHMIDT W MAASS G WAGNER E BUSCHLE M GIESE M KEMPE ER WEBER HA VOIGT T
Citation: G. Stingl et al., PHASE-I STUDY TO THE IMMUNOTHERAPY OF METASTATIC MALIGNANT-MELANOMA BY A CANCER VACCINE CONSISTING OF AUTOLOGOUS CANCER-CELLS TRANSFECTED WITH THE HUMAN IL-2 GENE, Human gene therapy, 7(4), 1996, pp. 551-563
LOSS OF TUMORIGENICITY OF INTERLEUKIN-2 PRODUCING M-3 MELANOMA-CELLS IS DUE TO INFILTRATING LEUKOCYTES - NK-CELLS PLAY A MAJOR ROLE
Authors: KOSZIK F SCHNEEBERGER A SCHMIDT W STROMMER S KUTIL R STINGL G
Citation: F. Koszik et al., LOSS OF TUMORIGENICITY OF INTERLEUKIN-2 PRODUCING M-3 MELANOMA-CELLS IS DUE TO INFILTRATING LEUKOCYTES - NK-CELLS PLAY A MAJOR ROLE, Journal of investigative dermatology, 107(3), 1996, pp. 6-6
IMMUNOPHENOTYPIC CHARACTERISTICS OF DENDRITIC CELLS DETERMINE THEIR BIOLOGIC FUNCTION IN-VIVO
Authors: LENZ P SCHNEEBERGER A ELBE A STINGL G
Citation: P. Lenz et al., IMMUNOPHENOTYPIC CHARACTERISTICS OF DENDRITIC CELLS DETERMINE THEIR BIOLOGIC FUNCTION IN-VIVO, Journal of investigative dermatology, 107(3), 1996, pp. 226-226
IL-4 ENHANCES THE YIELD AND THE IMMUNOSTIMULATORY POTENCY OF MURINE BONE-MARROW-DERIVED DENDRITIC CELLS
Authors: SCHNEEBERGER A KOSZIK F LENZ P KOLESARIC A SCHEINECKER C STRUNK D GRAUER O KAMPGEN E ELBE A STINGL G
Citation: A. Schneeberger et al., IL-4 ENHANCES THE YIELD AND THE IMMUNOSTIMULATORY POTENCY OF MURINE BONE-MARROW-DERIVED DENDRITIC CELLS, Journal of investigative dermatology, 107(3), 1996, pp. 232-232
THE RELATIVE CONTRIBUTION OF DIRECT VERSUS INDIRECT PRESENTATION IN PRIMING FOR CONTACT HYPERSENSITIVITY BY MHC CLASS-I-II- DENDRITIC CELLS( CLASS)
Authors: KOLESARIC A KOSZIK F SCHNEEBERGER A STINGL G ELBE A
Citation: A. Kolesaric et al., THE RELATIVE CONTRIBUTION OF DIRECT VERSUS INDIRECT PRESENTATION IN PRIMING FOR CONTACT HYPERSENSITIVITY BY MHC CLASS-I-II- DENDRITIC CELLS( CLASS), Journal of investigative dermatology, 107(3), 1996, pp. 234-234
TUMOR CELL-BEARING SKIN TRANSPLANTS AS POTENT IMMUNOGENS FOR PROTECTIVE IMMUNITY AGAINST CANCER
Authors: SCHNEEBERGER A KUTIL R KOSZIK F LENZ P STINGL G
Citation: A. Schneeberger et al., TUMOR CELL-BEARING SKIN TRANSPLANTS AS POTENT IMMUNOGENS FOR PROTECTIVE IMMUNITY AGAINST CANCER, Journal of investigative dermatology, 106(4), 1996, pp. 701-701
LOSS OF TUMORIGENICITY OF IL-2-PRODUCING MURINE MELANOMA-CELLS IS DEPENDENT ON THE HOSTS IMMUNE-SYSTEM AND THE AMOUNT OF IL-2 PRODUCED
Authors: KOSZIK F SCHNEEBERGER A SCHMIDT W STROMMER S KUTIL R STINGL G
Citation: F. Koszik et al., LOSS OF TUMORIGENICITY OF IL-2-PRODUCING MURINE MELANOMA-CELLS IS DEPENDENT ON THE HOSTS IMMUNE-SYSTEM AND THE AMOUNT OF IL-2 PRODUCED, Journal of investigative dermatology, 106(4), 1996, pp. 757-757
INTERLEUKIN-2 TRANSFECTED MELANOMA-CELLS FOR TUMOR VACCINATION - FROMANIMAL-MODELS TO CLINICAL-TRIALS
Authors: MAASS G SCHMIDT W SCHWEIGHOFFER T BERGER M SCHNEEBERGER A ZATLOUKAL K COTTEN M WAGNER E BIRNSTIEL ML
Citation: G. Maass et al., INTERLEUKIN-2 TRANSFECTED MELANOMA-CELLS FOR TUMOR VACCINATION - FROMANIMAL-MODELS TO CLINICAL-TRIALS, European journal of cancer, 31A, 1995, pp. 24-24
PRIMING OF TUMOR-SPECIFIC T-CELLS IN THE DRAINING LYMPH-NODES AFTER IMMUNIZATION WITH INTERLEUKIN 2-SECRETING TUMOR-CELLS - 3 CONSECUTIVE STAGES MAY BE REQUIRED FOR SUCCESSFUL TUMOR VACCINATION
Authors: MAASS G SCHMIDT W BERGER M SCHILCHER F KOSZIK F SCHNEEBERGER A STINGL G BIRNSTIEL ML SCHWEIGHOFFER T
Citation: G. Maass et al., PRIMING OF TUMOR-SPECIFIC T-CELLS IN THE DRAINING LYMPH-NODES AFTER IMMUNIZATION WITH INTERLEUKIN 2-SECRETING TUMOR-CELLS - 3 CONSECUTIVE STAGES MAY BE REQUIRED FOR SUCCESSFUL TUMOR VACCINATION, Proceedings of the National Academy of Sciences of the United Statesof America, 92(12), 1995, pp. 5540-5544
IMMUNOLOGICAL HOST-DEFENSE IN MELANOMA - DELINEATION OF EFFECTOR MECHANISMS INVOLVED AND OF STRATEGIES FOR THE AUGMENTATION OF THEIR EFFICACY
Authors: SCHNEEBERGER A KOSZIK F STINGL G
Citation: A. Schneeberger et al., IMMUNOLOGICAL HOST-DEFENSE IN MELANOMA - DELINEATION OF EFFECTOR MECHANISMS INVOLVED AND OF STRATEGIES FOR THE AUGMENTATION OF THEIR EFFICACY, Journal of investigative dermatology, 105(1), 1995, pp. 110-116
IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS OVERCOMES TUMOR-INDUCED IMMUNOSUPPRESSION
Authors: SCHNEEBERGER A KUTIL R KOSZIK F LAUB R BUSCHLE M WAGNER E BIRNSTIEL M STINGL G
Citation: A. Schneeberger et al., IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS OVERCOMES TUMOR-INDUCED IMMUNOSUPPRESSION, Journal of investigative dermatology, 104(4), 1995, pp. 681-681
ELICITATION OF A SYSTEMIC AND PROTECTIVE ANTIMELANOMA IMMUNE-RESPONSEBY AN IL-2-BASED VACCINE - ASSESSMENT OF CRITICAL CELLULAR AND MOLECULAR-PARAMETERS
Authors: ZATLOUKAL K SCHNEEBERGER A BERGER M SCHMIDT W KOSZIK F KUTIL R COTTEN M WAGNER E BUSCHLE M MAASS G PAYER E STINGL G BIRNSTIEL ML
Citation: K. Zatloukal et al., ELICITATION OF A SYSTEMIC AND PROTECTIVE ANTIMELANOMA IMMUNE-RESPONSEBY AN IL-2-BASED VACCINE - ASSESSMENT OF CRITICAL CELLULAR AND MOLECULAR-PARAMETERS, The Journal of immunology, 154(7), 1995, pp. 3406-3419
MECHANISMS LEADING TO IL-2 MEDIATED TUMOR REJECTION IN MURINE MELANOMA
Authors: MAASS G ZATLOUKAL K SCHNEEBERGER A SCHMIDT W BERGER M BUSCHLE M COTTEN M WAGNER E STINGL G BIRNSTIEL ML
Citation: G. Maass et al., MECHANISMS LEADING TO IL-2 MEDIATED TUMOR REJECTION IN MURINE MELANOMA, Journal of cellular biochemistry, 1994, pp. 239-239
ANTITUMOR EFFECTOR MECHANISMS GENERATED BY VACCINATION WITH INTERLEUKIN-2 TRANSFECTED MURINE MELANOMA-CELLS
Authors: SCHNEEBERGER A KOSZIK F ZATLOUKAL K KUTIL R ELBE A WAGNER E BIRNSTIEL ML STINGL G
Citation: A. Schneeberger et al., ANTITUMOR EFFECTOR MECHANISMS GENERATED BY VACCINATION WITH INTERLEUKIN-2 TRANSFECTED MURINE MELANOMA-CELLS, Journal of investigative dermatology, 103(3), 1994, pp. 408-408
IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS PROTECTS MICE AGAINST SUBSEQUENT CHALLENGE WITH WILD-TYPE M-3 CELLS - CHARACTERIZATION OF THE EFFECTOR POPULATIONS
Authors: KOSZIK F SCHNEEBERGER A ZATLOUKAL K PAYER E ELBE A WAGNER E BIRNSTIEL ML STINGL G
Citation: F. Koszik et al., IMMUNIZATION WITH IL-2-TRANSFECTED M-3 MELANOMA-CELLS PROTECTS MICE AGAINST SUBSEQUENT CHALLENGE WITH WILD-TYPE M-3 CELLS - CHARACTERIZATION OF THE EFFECTOR POPULATIONS, Journal of investigative dermatology, 102(4), 1994, pp. 583-583
Risultati: 1-25 | 26-26